BioCentury
ARTICLE | Product Development

NIH competition to encourage COVID-19 diagnostic innovation, pad U.S. testing capacity

BeiGene partners to explore differentiated antibody therapy as J&J finds second manufacturing partner

April 30, 2020 1:33 AM UTC
Updated on Apr 30, 2020 at 4:37 PM UTC

As dozens of leading biopharmas, research institutes and health agencies embrace precompetitive coalitions and master protocols to speed development of COVID-19 therapies and vaccines, NIH has created a competition to accelerate diagnostics.

The organization today launched the Rapid Acceleration of Diagnostics (RADx) Initiative, a national technology development competition to fuel the development of rapid and easy-to-use COVID-19 tests...